Share Price & News
How has Shenzhen Chipscreen Biosciences's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 688321 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 688321's weekly volatility (6%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 688321 underperformed the CN Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: 688321 underperformed the CN Market which returned 28.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Shenzhen Chipscreen Biosciences's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Shenzhen Chipscreen Biosciences undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 688321's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 688321's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 688321 is poor value based on its PE Ratio (486x) compared to the CN Pharmaceuticals industry average (31.2x).
PE vs Market: 688321 is poor value based on its PE Ratio (486x) compared to the CN market (33.9x).
Price to Earnings Growth Ratio
PEG Ratio: 688321 is poor value based on its PEG Ratio (8.7x)
Price to Book Ratio
PB vs Industry: 688321 is overvalued based on its PB Ratio (10.1x) compared to the CN Pharmaceuticals industry average (2.7x).
How is Shenzhen Chipscreen Biosciences forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688321's forecast earnings growth (55.6% per year) is above the savings rate (3.3%).
Earnings vs Market: 688321's earnings (55.6% per year) are forecast to grow faster than the CN market (23.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688321's revenue (48.6% per year) is forecast to grow faster than the CN market (17.9% per year).
High Growth Revenue: 688321's revenue (48.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688321's Return on Equity is forecast to be low in 3 years time (10.9%).
How has Shenzhen Chipscreen Biosciences performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 688321 has a high level of non-cash earnings.
Growing Profit Margin: 688321's current net profit margins (11.5%) are higher than last year (11.2%).
Past Earnings Growth Analysis
Earnings Trend: 688321's earnings have grown by 19.1% per year over the past 5 years.
Accelerating Growth: 688321's earnings growth over the past year (59.5%) exceeds its 5-year average (19.1% per year).
Earnings vs Industry: 688321 earnings growth over the past year (59.5%) exceeded the Pharmaceuticals industry 10.8%.
Return on Equity
High ROE: 688321's Return on Equity (2.1%) is considered low.
How is Shenzhen Chipscreen Biosciences's financial position?
Financial Position Analysis
Short Term Liabilities: 688321's short term assets (CN¥769.1M) exceed its short term liabilities (CN¥146.9M).
Long Term Liabilities: 688321's short term assets (CN¥769.1M) exceed its long term liabilities (CN¥85.6M).
Debt to Equity History and Analysis
Debt Level: 688321's debt to equity ratio (3.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 688321's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 688321's debt is well covered by operating cash flow (161.5%).
Interest Coverage: Insufficient data to determine if 688321's interest payments on its debt are well covered by EBIT.
What is Shenzhen Chipscreen Biosciences's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 688321's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 688321's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 688321's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 688321's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 688321's dividend in 3 years as they are not forecast to pay a notable one for the CN market.
How experienced are the management team and are they aligned to shareholders interests?
Dr. Xian-Ping Lu co-founded Shenzhen Chipscreen Biosciences Ltd. in 2001 and also serves as its Chief Executive Officer, President and Chief Scientific Officer. Dr. Lu serves as a Consultant at Efung Capit...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Shenzhen Chipscreen Biosciences Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Shenzhen Chipscreen Biosciences Co., Ltd.
- Ticker: 688321
- Exchange: SHSE
- Founded: 2001
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥15.084b
- Shares outstanding: 410.00m
- Website: https://www.chipscreen.com
Number of Employees
- Shenzhen Chipscreen Biosciences Co., Ltd.
- Biology Incubator Building 2
- Rooms 601 – 606
- Guangdong Province
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/11 09:31|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.